How to Own SpaceX Without Buying the IPO

SpaceX filed its S-1 on May 20, 2026, targeting a Nasdaq IPO with an implied valuation of $1.75 trillion to $2 trillion and roughly 5% of the company expected to float. The filing disclosed $18 billion of 2025 revenue, with Starlink contributing $11.4 billion, or 61% of total revenue, and $4.42 billion of profit from the connectivity segment. The article also highlights indirect retail exposure via XOVR and DXYZ, while framing Rocket Lab as a lower-valuation space-equity alternative with a $2.2 billion backlog and Q2 2026 revenue guidance of $225 million to $240 million.

Analysis

The IPO setup is less about the company itself than about the scarcity premium the float creates. A tiny public float against enormous retail and institutional demand can push the first leg well beyond fundamental value, but that same structure makes the trade path-dependent: once momentum slows, there is almost no natural buffer from secondary liquidity. The bigger second-order effect is that it will likely re-rate the entire private-tech complex, temporarily inflating marks for venture vehicles and late-stage crossover funds even if their underlying economics do not improve.

The cleaner relative-value implication is not to chase the headline asset, but to own the operational lever in the same theme. RKLB is the only liquid public proxy with identifiable catalysts that can convert sector attention into backlog conversion and multiple expansion over the next 2-4 quarters. If Neutron stays on schedule, the market can start underwriting a step-change in addressable market and margin mix; if it slips, the stock probably de-rates first on timeline credibility rather than on near-term revenue.

The biggest contrarian point is that retail is likely to overpay for indirect exposure while underpricing liquidity and mark risk. DXYZ looks especially vulnerable if the IPO excitement cools, because premium-to-NAV structures tend to mean-revert hardest when the narrative peak passes. XOVR is more defensible because the fee structure is modest, but the SPV/mark opacity means it can still trade like a sentiment instrument rather than a clean basket; that makes it useful tactically, not strategically.

Key Decisions for Investors

• Long RKLB vs short DXYZ for 3-6 months: pair the cleaner operating catalyst against the most sentiment-sensitive private-market wrapper; target 20-30% relative outperformance if Neutron milestones stay on track.
• Buy RKLB on pullbacks tied to IPO hype spikes, not strength: scale in only after intraday/weekly volatility subsides, because the stock should benefit from any confirmation of launch progress over the next 1-2 quarters.
• Fade DXYZ into enthusiasm spikes: initiate a tactical short or buy puts if the premium to NAV appears to widen further; this is a momentum-vs-liquidity mismatch with asymmetric downside once attention rotates.
• Use XOVR only as a temporary exposure vehicle, not a core hold: acceptable for a 1-3 month event trade, but trim if bid-ask spreads widen or if private marks lag public sentiment by more than one reporting cycle.
• Avoid chasing the IPO at the expected opening print: wait for post-lockup or post-deal cooling to evaluate whether the public market can digest the float without a volatility crush; the first tradable dip is likely the better risk/reward entry.